| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |